Clinical Trial Update: A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing octreotide depot to saline control in pediatric hypothalamic obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity

Drugs mentioned

• Octreotide Depot (octreotide)

Snippet

Sponsor: Novartis | Conditions: Hypothalamic Obesity | Phase 4 | Status: COMPLETED